Compare AU
Compare QRE vs. CURE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Australian Resources Sector ETF (QRE) and the Global X S&P Biotech ETF (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
QRE | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 91 | 82 |
Median incremental investment | $993.50 | $619.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,631.57 | $1,323.41 |
Average age group | > 35 | > 35 |
Key Summary
QRE | CURE | |
|---|---|---|
Strategy | QRE.AX was created on 2010-12-10 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. QRE.AX aims to track the performance an index (before fees and expenses) comprising the largest ASX-listed companies in the resources sector, including BHP, Rio Tinto, Woodside Petroleum and more. | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. |
Top 3 holdings | BHP GROUP LTD (40.58 %) WOODSIDE ENERGY GROUP LTD (10.31 %) RIO TINTO LTD (8.20 %) | Natera Inc (3.41 %) Incyte Corp (2.94 %) Gilead Sciences Inc (2.88 %) |
Top 3 industries | Materials (75.78 %) Energy (21.55 %) Other (2.67 %) | Health Care (100.00 %) Other (10.24 %) |
Top 3 countries | Australia (97.20 %) United States (2.39 %) China (0.41 %) | United States (97.17 %) Switzerland (1.51 %) United Kingdom of Great Britain and Northern Ireland (1.16 %) |
Management fee | 0.34 % | 0.45 % |
Key Summary
QRE | CURE | |
|---|---|---|
Issuer | BetaShares | Global X |
Tracking index | Solactive Australia Resources Sector Index - AUD - Benchmark TR Gross | S&P Biotechnology Select Industry |
Asset class | ETF | ETF |
Management fee | 0.34 % | 0.45 % |
Price | $6.77 | $49.94 |
Size | $302.666 million | $38.065 million |
10Y return | 46.54 % | N/A |
Annual distribution yield (5Y) | 8.87 % | 4.24 % |
Market | ASX | ASX |
First listed date | 15/12/2010 | 12/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
QRE | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 91 | 82 |
Median incremental investment | $993.50 | $619.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,631.57 | $1,323.41 |
Average age group | > 35 | > 35 |
Pros and Cons
QRE | CURE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
QRE | CURE |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |